Cochlear Osake

Cochlear P/CF

P/CF (Hinta-kassavirta-suhde) yhtiöstä Cochlear (COH.AX) 21.6.2026 päivämäärällä on 47,46.Edellisenä vuonna P/CF (Hinta-kassavirta-suhde) oli 29 — muutos 63,64 % (korkeampi).

P/CF

47,46

YoY

63,64%

Viimeksi päivitetty:

P/CF (Hinta-kassavirta-suhde) yhtiöstä Cochlear on 2026 47,46 . P/CF (Hinta-kassavirta-suhde) yhtiöstä Cochlear oli 2025 29 . Se laskee 63,64% korkeampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Cochlear Osakeanalyysi

Mitä Cochlear tekee? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Cochlear osakkeesta

P/CF (Hinta-kassavirta-suhde) oli Cochlear 29 47,46

Access this data via the Eulerpool API

Arvostus — Cochlear

Kaikki tunnusluvut — Cochlear